Business Wire

NTT-COMMUNICATIONS

27.3.2024 01:01:32 CET | Business Wire | Press release

Share
NTT Communications: Digital Event Connects Tokyo and Kanazawa via World's Longest IOWN APN to Commemorate Hokuriku Shinkansen Line's Extension

NTT Communications Corporation (NTT Com) and the Hokuriku Regional Office of NTT DOCOMO, INC. (DOCOMO), together with the city of Kanazawa, celebrated the opening of a new section of the Hokuriku Shinkansen Line between Kanazawa and Tsuruga by holding digital events on March 16 under the theme of "Connection," a key component of NTT Group’s Innovative Optical and Wireless Network (IOWN) concept.1

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240325762257/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Scheme of live remote performance (Graphic: Business Wire)

The events included a live remote performance that seamlessly connected musicians in Kanazawa and Tokyo, a distance of about 1,000 kilometers, via the All-Photonics Network (APN). For the connection, NTT Com provided its APN Leased Line Plan powered by IOWN,2 which used the longest optical cable ever deployed in an IOWN demonstration and the first to be deployed in Japan's Hokuriku region.

The event brought together the Kanazawa Junior Jazz Orchestra JAZZ-21, consisting mainly of middle and high school students who have performed at the areas affected by the Great East Japan Earthquake and various major festivals around the world, and celebrated violinist Mayu Kijima, winner of numerous international competitions, including the 1st Shanghai Isaac Stern International Violin Competition in 2016, who performed with the Walner violin made by Antonio Stradivari 1699, which was on loan from the Munetsugu Collection.

Kanazawa City provided the demonstration environment and operated the venue in its area and NTT Com provided the APN transmission equipment and the venue in Tokyo. NTT Com and DOCOMO livestreamed the event on Kanazawa's metaverse platform using DOCOMO's 5G video transmission system, allowing viewers at home to enjoy the live event on PCs, smartphones and tablets via the browser-based virtual space platform DOOR.3 In addition, DOCOMO used its Hide Mode4 function to allow more people than normal to enter the virtual room. This was the first time in Japan that a metaverse space open to the public was used for a music event.

In another demonstration, smart lighting was used to allow spectators to digitally interact with Kanazawa's famous Tsuzumi-mon Gate to influence its illumination on the evening of March 16. Using 5G communication and IoT technology, spectators were able change the illumination by selecting from eight patterns via tablets placed near the gate. The demonstration, called “Connecting with Tsuzumi-mon Gate,” allowed people to make a special connection with the iconic site, including to take commemorative photos.

A third commemorative demonstration on March 16, called “Connecting with Other Locations,” allowed visitors to the Underground Plaza of the Motenashi Dome near Kanazawa Station to view and experience famous scenes along the Hokuriku Shinkansen line via a wide-angle virtual reality display without the use of goggles. During the demonstration, multiple people simultaneously enjoyed videos, 360-degree images and metaverse spaces, and even the experience of sitting in a Shinkansen driver's seat while traveling on the newly extended Hokuriku Shinkansen line.

DOCOMO group, under an agreement signed with the city of Kanazawa and West Japan Railway Company in 2019, is working to promote local attractions using 5G and other advanced technologies. Following the recent Noto Peninsula Earthquake on January 1, DOCOMO has strengthened its efforts to work with the people of the Hokuriku region to revitalize the region and support its recovery and reconstruction. Going forward, based on the lessons learned from the event to commemorate the Hokuriku Shinkansen Line's extension, NTT Com and DOCOMO are committed to providing new value to Kanazawa citizens and customers by incorporating new technologies, including the IOWN APN where possible, to promote the attractiveness of Kanazawa and contribute to the revitalization of the region.

1 Network infrastructure concept for creating an enriched society using advanced optical technologies, etc. IOWN® is a trademark of NTT Corporation. https://www.rd.ntt/e/iown/
2 NTT Com began offering APN communication services spanning prefectures from March 1 to meet customers' needs for advanced communication infrastructure.
3 DOCOMO's subsidiary NTT QONOQ INC. (https://www.nttqonoq.com/?lang=en) provides this service for holding events and displaying content in virtual spaces.
4 While 24 people is the normal recommended capacity of a virtual room, Hide Mode is a paid option that allows hundreds of people to enter, with certain limited capabilities. Please visit https://door.ntt/web/faq/index.html.

About NTT Communications
NTT Communications solves global technology challenges by helping enterprises utilize managed IT-infrastructure solutions to overcome complexity and risk in their IT environments. These solutions are backed by our worldwide infrastructure, including industry-leading, global tier-1 public and private networks reaching over 190 countries/regions, the world's most advanced data-center facilities (more than 500,000m2) and cutting-edge technologies for cloud, security and AI. As the core provider of the DOCOMO group's enterprise-business services and solutions, we create value by providing global-scale support for restructuring in industry and society, new workstyles and digital transformation in communities, leveraging 5G, IoT and other technologies under the "docomo business" brand. Together with NTT Ltd., NTT Data and NTT DOCOMO, we are the NTT Group.
www.ntt.com | Twitter@NTT Com | Facebook@NTT Com

About NTT DOCOMO
NTT DOCOMO, Japan’s leading mobile operator with over 89 million subscriptions, is one of the world’s foremost contributors to 3G, 4G and 5G mobile network technologies. Beyond core communications services, DOCOMO is challenging new frontiers in collaboration with a growing number of entities ("+d" partners), creating exciting and convenient value-added services that change the way people live and work. Under a medium-term plan toward 2020 and beyond, DOCOMO is pioneering a leading-edge 5G network to facilitate innovative services that will amaze and inspire customers beyond their expectations.
https://www.docomo.ne.jp/english/

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240325762257/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye